Zhejiang Shengda Bio-Pharm Co., Ltd.
SSE:603079.SS
16.54 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 315.619 | 323.722 | 320.718 | 514.748 | 461.312 | 327.471 | 301.269 | 294.533 | 176.19 | 108.561 | 63.058 | 132.891 | 72.08 |
| Short Term Investments
| 0.015 | 3.014 | 10 | 0.014 | -11.18 | -8.739 | 15.024 | 0 | 0 | 0 | 0 | 0 | -1.339 |
| Cash and Short Term Investments
| 315.633 | 326.736 | 320.718 | 514.762 | 461.312 | 327.471 | 316.294 | 294.533 | 176.19 | 108.561 | 63.058 | 132.891 | 72.08 |
| Net Receivables
| 141.791 | 119.858 | 135.902 | 133.379 | 115.019 | 107.955 | 106.498 | 116.164 | 75.759 | 66.077 | 75.188 | 45.799 | 63.881 |
| Inventory
| 197.536 | 228.482 | 292.062 | 222.088 | 167.942 | 174.621 | 124.815 | 99.45 | 122.12 | 107.965 | 69.12 | 45.773 | 83.044 |
| Other Current Assets
| 53.808 | 20.073 | 31.681 | 48.586 | 136.872 | 110.407 | 36.694 | 106.184 | 12.317 | 14.806 | 13.271 | 7.89 | 65.589 |
| Total Current Assets
| 708.768 | 695.149 | 780.363 | 918.815 | 881.146 | 720.453 | 569.777 | 616.331 | 386.386 | 297.41 | 220.637 | 232.354 | 220.713 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 769.468 | 674.771 | 561.813 | 579.958 | 576.019 | 577.887 | 479.003 | 235.231 | 225.93 | 191.399 | 152.428 | 152.948 | 138.963 |
| Goodwill
| 10.909 | 10.909 | 10.909 | 10.909 | 10.909 | 10.909 | 10.909 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 225.58 | 231.816 | 218.198 | 156.087 | 165.587 | 175.603 | 128.815 | 119.898 | 128.018 | 134.341 | 112.057 | 118.907 | 127.029 |
| Goodwill and Intangible Assets
| 236.489 | 242.725 | 229.107 | 166.996 | 176.497 | 186.513 | 139.725 | 119.898 | 128.018 | 134.341 | 112.057 | 118.907 | 127.029 |
| Long Term Investments
| 10.685 | 10.7 | 60.7 | 10.686 | 21.88 | 9.239 | -14.524 | 0.5 | 0 | -0.985 | 0 | 0 | 6.339 |
| Tax Assets
| 0.064 | 0.889 | 5.355 | 3.385 | 2.888 | 3.457 | 1.868 | 1.47 | 1.04 | 0.986 | 1.249 | 0.88 | 0.85 |
| Other Non-Current Assets
| 59.837 | 95.841 | 17.869 | 84.975 | 42.439 | 35.041 | 76.862 | 12.55 | -0 | 0.985 | 61.899 | -0 | 13.53 |
| Total Non-Current Assets
| 1,076.543 | 1,024.037 | 874.844 | 845.999 | 819.723 | 812.137 | 682.934 | 369.649 | 354.988 | 326.725 | 327.633 | 272.735 | 286.71 |
| Total Assets
| 1,785.311 | 1,719.186 | 1,655.208 | 1,764.814 | 1,700.869 | 1,532.59 | 1,252.71 | 985.98 | 741.374 | 624.135 | 548.27 | 505.088 | 507.423 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 172.992 | 129.613 | 164.002 | 164.635 | 3.798 | 162.275 | 152.484 | 78.249 | 98.779 | 99.988 | 85.855 | 77.327 | 88.462 |
| Short Term Debt
| 30.028 | 94.298 | 41.759 | 155.716 | 172.743 | 105.795 | 185.373 | 70.271 | 65 | 42.537 | 80 | 87.5 | 63.05 |
| Tax Payables
| 13.218 | 11 | 13.802 | 12.458 | 26.826 | 3.98 | 4.314 | 5.766 | 7.187 | 11.608 | 4.631 | 1.574 | 6.512 |
| Deferred Revenue
| 0 | 0.902 | 8.703 | 91.244 | 111.609 | 100.616 | 4.314 | 34.65 | 96.871 | 35.843 | 23.184 | 16.867 | 99.291 |
| Other Current Liabilities
| 35.146 | 59.641 | 75.9 | 73.145 | 202.864 | 99.477 | 74.672 | 69.011 | 100.421 | 24.242 | 34.578 | 16.23 | 97.339 |
| Total Current Liabilities
| 251.384 | 295.454 | 295.463 | 412.496 | 358.755 | 371.527 | 416.844 | 215.466 | 271.387 | 182.731 | 205.064 | 182.631 | 255.363 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 231.493 | 144 | 0.304 | 0.871 | 1.431 | 244.458 | 5 | 0 | 27.5 | 0 | 16 | 38.25 | 65.75 |
| Deferred Revenue Non-Current
| 6.65 | 5.464 | 7.583 | 6.946 | 4.689 | 1.143 | 1.256 | 1.807 | 2.465 | 2.317 | 2.334 | 3.12 | 0.315 |
| Deferred Tax Liabilities Non-Current
| 3.71 | 4.277 | 8.412 | 7.529 | 6.438 | 3.754 | 1.194 | 0 | -27.5 | 0 | 0 | -38.25 | -65.75 |
| Other Non-Current Liabilities
| 8.1 | 0 | 8.412 | 0 | 4.489 | 0 | 0 | 0 | 0 | 0 | 0 | 3.12 | 0 |
| Total Non-Current Liabilities
| 249.953 | 153.741 | 16.299 | 15.346 | 17.048 | 249.354 | 7.45 | 1.807 | 29.965 | 2.317 | 18.334 | 41.37 | 66.065 |
| Total Liabilities
| 501.337 | 449.196 | 311.762 | 427.843 | 375.803 | 620.881 | 424.294 | 217.273 | 301.352 | 185.048 | 223.398 | 224.001 | 321.428 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 171.189 | 171.189 | 171.189 | 171.189 | 171.189 | 112 | 112 | 80 | 60 | 60 | 60 | 60 | 23.08 |
| Retained Earnings
| 383.962 | 366.005 | 430.355 | 423.427 | 411.546 | 247.374 | 216.98 | 199.604 | 132.711 | 137.823 | 60.878 | 21.032 | 57.338 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 57.259 | 57.259 | 56.668 | 52.709 | 93.088 | 30.919 | 25.75 | 20.033 | 13.986 | 0 | -0 | 0 |
| Other Total Stockholders Equity
| 705.681 | 660.228 | 726.47 | 725.862 | 721.903 | 431.353 | 462.271 | 489.103 | 247.311 | 241.264 | 199.767 | 199.767 | 73.627 |
| Total Shareholders Equity
| 1,260.832 | 1,254.681 | 1,327.997 | 1,320.478 | 1,304.637 | 883.815 | 791.252 | 768.707 | 440.022 | 439.087 | 324.872 | 281.087 | 154.045 |
| Total Equity
| 1,283.974 | 1,269.99 | 1,343.446 | 1,336.971 | 1,325.066 | 911.709 | 828.417 | 768.707 | 440.022 | 439.087 | 324.872 | 281.087 | 185.995 |
| Total Liabilities & Shareholders Equity
| 1,785.311 | 1,719.186 | 1,655.208 | 1,764.814 | 1,700.869 | 1,532.59 | 1,252.71 | 985.98 | 741.374 | 624.135 | 548.27 | 505.088 | 507.423 |